Caris & Co. downgrades Onyx Pharmaceuticals (Nasdaq: ONXX) from Buy to Above Average.

Shares of Onyx ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE